Journey Colab

Sam Altman, co-founder of OpenAI and the visionary behind ChatGPT, recently opened up about his transformative experiences with psychedelics in his appearance on the podcast Life in Seven Songs. The tech executive shared personal anecdotes about how psychedelic experiences profoundly impacted his...

Two markets that have so far not been as extensively interconnected, but could soon be. Each goes at its own pace and touches on very distinct areas of human activity — or not as much? Psychedelics research shows robust evidence on the potential benefits for numerous health conditions,...

National addiction expert Kelly J. Clark, MD has joined the scientific advisory board of mission-driven psychedelic startup Journey Colab, Benzinga has learned exclusively. Clark will support Journey’s drug development program and new model of addiction care that combines psychedelic science...